| Sign In to gain access to subscriptions and/or personal tools. |
HFA-134a (1,1,1,2-tetrafluoroethane): effects of inhalation exposure upon reproductive performance, development and maturation of ratsMedicines Safety Evaluation Division, Glaxo Wellcome Research & Development Ltd., Ware, Hertfordshire SG12 ODP
Medicines Safety Evaluation Division, Glaxo Wellcome Research & Development Ltd., Ware, Hertfordshire SG12 ODP
Medicines Safety Evaluation Division, Glaxo Wellcome Research & Development Ltd., Ware, Hertfordshire SG12 ODP
Division of Toxicology, Huntingdon Life Sciences Ltd., PO Box 2, Huntingdon, Cambridgeshire PE18 6ES, UK
Division of Toxicology, Huntingdon Life Sciences Ltd., PO Box 2, Huntingdon, Cambridgeshire PE18 6ES, UK 1 HFA-134a was administered to AHA rats by snout-only inhalation for 1 h daily to assess the effects of treatment on reproduction and development. 2 In a fertility study, rats were exposed to atmospheres of 2500, 10000 or 50000 p.p.m. HFA-134a throughout gametogenesis, mating, pregnancy and lactation. 3 In a peri- and post-natal study, rats were exposed to HFA-134a from days 17 to 20 of pregnancy and days 1 to 21 post partum to atmospheres of 1800, 9900 or 64 400 p.p.m. 4 The only treatment-related effect was a slight reduc tion in body weight gain of males of the treated parental generation at 50 000 p.p.m. (fertility study). 5 In neither study were there any adverse effects of HFA- 134a on the reproductive performance of treated animals or on the development, maturation or reproductive performance of up to two successive generations.
Key Words: HFA-134a inhalation reproductive toxicology rats
Human & Experimental Toxicology, Vol. 15, No. 6,
508-517 (1996) This article has been cited by other articles:
|
|||||||||||||||
